The IVD Contract Manufacturing Market was valued at USD 21.61 billion in 2025 and is projected to reach USD 43.79 billion by 2033, with a CAGR of 9.31% from 2026-2033. This growth is driven by increased demand for in vitro diagnostic products and the trend of outsourcing manufacturing to specialized manufacturers.
In the U.S., the IVD Contract Manufacturing Market was valued at USD 8.09 billion in 2025 and is expected to reach USD 16.05 billion by 2033, with a CAGR of 9.01% from 2026-2033. Advancements in automation, quality standards, and the prevalence of chronic and infectious diseases are supporting market expansion.
The global IVD Contract Manufacturing Market is witnessing growth due to rising demand for diagnostic tests and increasing outsourcing by IVD companies. Contract manufacturing helps organizations cut operational expenses, expedite product development, and meet regulatory deadlines, driving market growth.
Major players in the IVD Contract Manufacturing Market include Thermo Fisher Scientific, Jabil Inc., Sanmina Corporation, and more. These players contribute to market growth through their expertise in specialized manufacturing and innovative solutions.
The IVD Contract Manufacturing Market is segmented by product, service, technology, and end-use. Reagents & Consumables dominate the market, while Manufacturing Services hold the largest revenue share. Immunoassays and Molecular Diagnostics are key technology segments driving market growth.
North America leads the IVD Contract Manufacturing Market with a 43% share in 2025, while Asia Pacific is projected to grow at the fastest CAGR of around 11.36% from 2026-2033. The market is driven by the need for affordable diagnostic solutions and increasing prevalence of chronic and infectious diseases.
Recent developments in the IVD Contract Manufacturing Market include the launch of innovative platforms such as TCS Rapid Path and Invetech Flex Cell. These advancements aim to improve infectious disease testing and support decentralized production of cell therapy and regenerative medicines.
Read more at GlobeNewswire: IVD Contract Manufacturing Market Size to Reach USD 43.79